Clinical Trial Update: Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma [NA]

View source ↗

Summary

A clinical trial investigating genetically modified peripheral blood stem cell transplantation for HIV-associated lymphomas has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Hodgkin Lymphoma
• Hiv-associated Non-hodgkin Lymphoma

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, AIDS-related Diffuse Large Cell Lymphoma | NA | Status: WITHDRAWN